시장조사 보고서 : 세계의 이식 가능형 심장 재동기 치료 장치 시장예측 2021년-2026년

■ 영문 제목 : Global Implantable Cardiac Resynchronization Therapy Devices Market Growth 2021-2026
	■ 상품코드 : LPI-2201K00268 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 97 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 이식 가능형 심장 재동기 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (제세동기 (CRT-D), 페이스메이커 (CRT-P), 기타)와 용도별 시장규모 (병원, 클리닉, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 이식 가능형 심장 재동기 치료 장치 시장 점유율
- 지역별 이식 가능형 심장 재동기 치료 장치 시장규모
- 주요지역의 종류별 시장규모 (제세동기 (CRT-D), 페이스메이커 (CRT-P), 기타)
- 주요지역의 용도별 시장규모 (병원, 클리닉, 기타)
- 미주의 이식 가능형 심장 재동기 치료 장치 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 이식 가능형 심장 재동기 치료 장치 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 이식 가능형 심장 재동기 치료 장치 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 이식 가능형 심장 재동기 치료 장치 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 이식 가능형 심장 재동기 치료 장치 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Medtronic, Abbott, ZOLL Medical Corporation, Boston Scientific Corporation, Biotronik, Koninklijke Philips N.V., Sorin Group, Nihon Kohden
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Implantable Cardiac Resynchronization Therapy Devices will have significant change from previous year. By the most conservative estimates of global Implantable Cardiac Resynchronization Therapy Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Implantable Cardiac Resynchronization Therapy Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Cardiac Resynchronization Therapy Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Defibrillator (CRT-D)
Pacemaker (CRT-P)
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Medtronic
Abbott
ZOLL Medical Corporation
Boston Scientific Corporation
Biotronik
Koninklijke Philips N.V.
Sorin Group
Nihon Kohden

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Implantable Cardiac Resynchronization Therapy Devices Consumption 2016-2026
2.1.2 Implantable Cardiac Resynchronization Therapy Devices Consumption CAGR by Region
2.2 Implantable Cardiac Resynchronization Therapy Devices Segment by Type
2.2.1 Defibrillator (CRT-D)
2.2.2 Pacemaker (CRT-P)
2.2.3 Other
2.3 Implantable Cardiac Resynchronization Therapy Devices Sales by Type
2.3.1 Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2016-2021)
2.3.2 Global Implantable Cardiac Resynchronization Therapy Devices Revenue and Market Share by Type (2016-2021)
2.3.3 Global Implantable Cardiac Resynchronization Therapy Devices Sale Price by Type (2016-2021)
2.4 Implantable Cardiac Resynchronization Therapy Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Implantable Cardiac Resynchronization Therapy Devices Sales by Application
2.5.1 Global Implantable Cardiac Resynchronization Therapy Devices Sale Market Share by Application (2016-2021)
2.5.2 Global Implantable Cardiac Resynchronization Therapy Devices Revenue and Market Share by Application (2016-2021)
2.5.3 Global Implantable Cardiac Resynchronization Therapy Devices Sale Price by Application (2016-2021)

3 Global Implantable Cardiac Resynchronization Therapy Devices by Company
3.1 Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Company
3.1.1 Global Implantable Cardiac Resynchronization Therapy Devices Sales by Company (2019-2021)
3.1.2 Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Company (2019-2021)
3.2 Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Company
3.2.1 Global Implantable Cardiac Resynchronization Therapy Devices Revenue by Company (2019-2021)
3.2.2 Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Company (2019-2021)
3.3 Global Implantable Cardiac Resynchronization Therapy Devices Sale Price by Company
3.4 Global Manufacturers Implantable Cardiac Resynchronization Therapy Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Cardiac Resynchronization Therapy Devices Product Location Distribution
3.4.2 Players Implantable Cardiac Resynchronization Therapy Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Implantable Cardiac Resynchronization Therapy Devices by Region
4.1 Global Implantable Cardiac Resynchronization Therapy Devices by Region
4.1.1 Global Implantable Cardiac Resynchronization Therapy Devices Sales by Region
4.1.2 Global Implantable Cardiac Resynchronization Therapy Devices Revenue by Region
4.2 Americas Implantable Cardiac Resynchronization Therapy Devices Sales Growth
4.3 APAC Implantable Cardiac Resynchronization Therapy Devices Sales Growth
4.4 Europe Implantable Cardiac Resynchronization Therapy Devices Sales Growth
4.5 Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Growth

5 Americas
5.1 Americas Implantable Cardiac Resynchronization Therapy Devices Sales by Country
5.1.1 Americas Implantable Cardiac Resynchronization Therapy Devices Sales by Country (2016-2021)
5.1.2 Americas Implantable Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2021)
5.2 Americas Implantable Cardiac Resynchronization Therapy Devices Sales by Type
5.3 Americas Implantable Cardiac Resynchronization Therapy Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Implantable Cardiac Resynchronization Therapy Devices Sales by Region
6.1.1 APAC Implantable Cardiac Resynchronization Therapy Devices Sales by Region (2016-2021)
6.1.2 APAC Implantable Cardiac Resynchronization Therapy Devices Revenue by Region (2016-2021)
6.2 APAC Implantable Cardiac Resynchronization Therapy Devices Sales by Type
6.3 APAC Implantable Cardiac Resynchronization Therapy Devices Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Implantable Cardiac Resynchronization Therapy Devices by Country
7.1.1 Europe Implantable Cardiac Resynchronization Therapy Devices Sales by Country (2016-2021)
7.1.2 Europe Implantable Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2021)
7.2 Europe Implantable Cardiac Resynchronization Therapy Devices Sales by Type
7.3 Europe Implantable Cardiac Resynchronization Therapy Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices by Country
8.1.1 Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales by Country (2016-2021)
8.1.2 Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2021)
8.2 Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales by Type
8.3 Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Implantable Cardiac Resynchronization Therapy Devices Distributors
10.3 Implantable Cardiac Resynchronization Therapy Devices Customer

11 Global Implantable Cardiac Resynchronization Therapy Devices Market Forecast
11.1 Global Implantable Cardiac Resynchronization Therapy Devices Forecast by Region
11.1.1 Global Implantable Cardiac Resynchronization Therapy Devices Forecast by Regions (2021-2026)
11.2.2 Global Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Implantable Cardiac Resynchronization Therapy Devices Forecast by Type
11.7 Global Implantable Cardiac Resynchronization Therapy Devices Forecast by Application

12 Key Players Analysis
12.1 Medtronic
12.1.1 Medtronic Company Information
12.1.2 Medtronic Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.1.3 Medtronic Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Medtronic Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Abbott
12.2.1 Abbott Company Information
12.2.2 Abbott Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.2.3 Abbott Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Abbott Main Business Overview
12.2.5 Abbott Latest Developments
12.3 ZOLL Medical Corporation
12.3.1 ZOLL Medical Corporation Company Information
12.3.2 ZOLL Medical Corporation Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.3.3 ZOLL Medical Corporation Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 ZOLL Medical Corporation Main Business Overview
12.3.5 ZOLL Medical Corporation Latest Developments
12.4 Boston Scientific Corporation
12.4.1 Boston Scientific Corporation Company Information
12.4.2 Boston Scientific Corporation Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.4.3 Boston Scientific Corporation Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Boston Scientific Corporation Main Business Overview
12.4.5 Boston Scientific Corporation Latest Developments
12.5 Biotronik
12.5.1 Biotronik Company Information
12.5.2 Biotronik Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.5.3 Biotronik Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Biotronik Main Business Overview
12.5.5 Biotronik Latest Developments
12.6 Koninklijke Philips N.V.
12.6.1 Koninklijke Philips N.V. Company Information
12.6.2 Koninklijke Philips N.V. Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.6.3 Koninklijke Philips N.V. Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Koninklijke Philips N.V. Main Business Overview
12.6.5 Koninklijke Philips N.V. Latest Developments
12.7 Sorin Group
12.7.1 Sorin Group Company Information
12.7.2 Sorin Group Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.7.3 Sorin Group Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sorin Group Main Business Overview
12.7.5 Sorin Group Latest Developments
12.8 Nihon Kohden
12.8.1 Nihon Kohden Company Information
12.8.2 Nihon Kohden Implantable Cardiac Resynchronization Therapy Devices Product Offered
12.8.3 Nihon Kohden Implantable Cardiac Resynchronization Therapy Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Nihon Kohden Main Business Overview
12.8.5 Nihon Kohden Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Implantable Cardiac Resynchronization Therapy Devices Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Defibrillator (CRT-D)
Table 3. Major Players of Pacemaker (CRT-P)
Table 4. Major Players of Other
Table 5. Global Implantable Cardiac Resynchronization Therapy Devices Sales by Type (2016-2021) & (K Units)
Table 6. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2016-2021)
Table 7. Global Implantable Cardiac Resynchronization Therapy Devices Revenue by Type (2016-2021) & ($ million)
Table 8. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Type (2016-2021)
Table 9. Global Implantable Cardiac Resynchronization Therapy Devices Sale Price by Type (2016-2021)
Table 10. Global Implantable Cardiac Resynchronization Therapy Devices Sales by Application (2016-2021) & (K Units)
Table 11. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2016-2021)
Table 12. Global Implantable Cardiac Resynchronization Therapy Devices Value by Application (2016-2021)
Table 13. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Application (2016-2021)
Table 14. Global Implantable Cardiac Resynchronization Therapy Devices Sale Price by Application (2016-2021)
Table 15. Global Implantable Cardiac Resynchronization Therapy Devices Sales by Company (2019-2021) & (K Units)
Table 16. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Company (2019-2021)
Table 17. Global Implantable Cardiac Resynchronization Therapy Devices Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Company (2019-2021)
Table 19. Global Implantable Cardiac Resynchronization Therapy Devices Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Implantable Cardiac Resynchronization Therapy Devices Producing Area Distribution and Sales Area
Table 21. Players Implantable Cardiac Resynchronization Therapy Devices Products Offered
Table 22. Implantable Cardiac Resynchronization Therapy Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Implantable Cardiac Resynchronization Therapy Devices Sales by Region (2016-2021) (K Units)
Table 26. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Region (2016-2021)
Table 27. Global Implantable Cardiac Resynchronization Therapy Devices Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Region (2016-2021)
Table 29. Americas Implantable Cardiac Resynchronization Therapy Devices Sales by Country (2016-2021) & (K Units)
Table 30. Americas Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2016-2021)
Table 31. Americas Implantable Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2016-2021)
Table 33. Americas Implantable Cardiac Resynchronization Therapy Devices Sales by Type (2016-2021) & (K Units)
Table 34. Americas Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2016-2021)
Table 35. Americas Implantable Cardiac Resynchronization Therapy Devices Sales by Application (2016-2021) & (K Units)
Table 36. Americas Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2016-2021)
Table 37. APAC Implantable Cardiac Resynchronization Therapy Devices Sales by Region (2016-2021) & (K Units)
Table 38. APAC Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Region (2016-2021)
Table 39. APAC Implantable Cardiac Resynchronization Therapy Devices Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Region (2016-2021)
Table 41. APAC Implantable Cardiac Resynchronization Therapy Devices Sales by Type (2016-2021) & (K Units)
Table 42. APAC Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2016-2021)
Table 43. APAC Implantable Cardiac Resynchronization Therapy Devices Sales by Application (2016-2021) & (K Units)
Table 44. APAC Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2016-2021)
Table 45. Europe Implantable Cardiac Resynchronization Therapy Devices Sales by Country (2016-2021) & (K Units)
Table 46. Europe Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2016-2021)
Table 47. Europe Implantable Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2016-2021)
Table 49. Europe Implantable Cardiac Resynchronization Therapy Devices Sales by Type (2016-2021) & (K Units)
Table 50. Europe Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2016-2021)
Table 51. Europe Implantable Cardiac Resynchronization Therapy Devices Sales by Application (2016-2021) & (K Units)
Table 52. Europe Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Implantable Cardiac Resynchronization Therapy Devices
Table 62. Key Application and Potential Industries of Implantable Cardiac Resynchronization Therapy Devices
Table 63. Key Challenges of Implantable Cardiac Resynchronization Therapy Devices
Table 64. Key Trends of Implantable Cardiac Resynchronization Therapy Devices
Table 65. Implantable Cardiac Resynchronization Therapy Devices Distributors List
Table 66. Implantable Cardiac Resynchronization Therapy Devices Customer List
Table 67. Global Implantable Cardiac Resynchronization Therapy Devices Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Implantable Cardiac Resynchronization Therapy Devices Consumption Market Forecast by Region
Table 69. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Implantable Cardiac Resynchronization Therapy Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Implantable Cardiac Resynchronization Therapy Devices Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Implantable Cardiac Resynchronization Therapy Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Implantable Cardiac Resynchronization Therapy Devices Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Implantable Cardiac Resynchronization Therapy Devices Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share Forecast by Application (2021-2026)
Table 87. Medtronic Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Medtronic Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 89. Medtronic Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Medtronic Main Business
Table 91. Medtronic Latest Developments
Table 92. Abbott Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 94. Abbott Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. ZOLL Medical Corporation Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. ZOLL Medical Corporation Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 99. ZOLL Medical Corporation Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. ZOLL Medical Corporation Main Business
Table 101. ZOLL Medical Corporation Latest Developments
Table 102. Boston Scientific Corporation Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Boston Scientific Corporation Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 104. Boston Scientific Corporation Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Boston Scientific Corporation Main Business
Table 106. Boston Scientific Corporation Latest Developments
Table 107. Biotronik Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Biotronik Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 109. Biotronik Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Biotronik Main Business
Table 111. Biotronik Latest Developments
Table 112. Koninklijke Philips N.V. Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. Koninklijke Philips N.V. Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 114. Koninklijke Philips N.V. Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Koninklijke Philips N.V. Main Business
Table 116. Koninklijke Philips N.V. Latest Developments
Table 117. Sorin Group Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. Sorin Group Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 119. Sorin Group Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Sorin Group Main Business
Table 121. Sorin Group Latest Developments
Table 122. Nihon Kohden Basic Information, Implantable Cardiac Resynchronization Therapy Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. Nihon Kohden Implantable Cardiac Resynchronization Therapy Devices Product Offered
Table 124. Nihon Kohden Implantable Cardiac Resynchronization Therapy Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Nihon Kohden Main Business
Table 126. Nihon Kohden Latest Developments
List of Figures
Figure 1. Picture of Implantable Cardiac Resynchronization Therapy Devices
Figure 2. Implantable Cardiac Resynchronization Therapy Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Cardiac Resynchronization Therapy Devices Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Implantable Cardiac Resynchronization Therapy Devices Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Defibrillator (CRT-D)
Figure 10. Product Picture of Pacemaker (CRT-P)
Figure 11. Product Picture of Other
Figure 12. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type in 2020
Figure 13. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Type (2016-2021)
Figure 14. Implantable Cardiac Resynchronization Therapy Devices Consumed in Hospital
Figure 15. Global Implantable Cardiac Resynchronization Therapy Devices Market: Hospital (2016-2021) & (K Units)
Figure 16. Implantable Cardiac Resynchronization Therapy Devices Consumed in Clinic
Figure 17. Global Implantable Cardiac Resynchronization Therapy Devices Market: Clinic (2016-2021) & (K Units)
Figure 18. Implantable Cardiac Resynchronization Therapy Devices Consumed in Other
Figure 19. Global Implantable Cardiac Resynchronization Therapy Devices Market: Other (2016-2021) & (K Units)
Figure 20. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2016-2021)
Figure 21. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Application in 2020
Figure 22. Implantable Cardiac Resynchronization Therapy Devices Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Company in 2020
Figure 24. Global Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Regions (2016-2021)
Figure 25. Global Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Region in 2020
Figure 26. Americas Implantable Cardiac Resynchronization Therapy Devices Sales 2016-2021 (K Units)
Figure 27. Americas Implantable Cardiac Resynchronization Therapy Devices Revenue 2016-2021 ($ Millions)
Figure 28. APAC Implantable Cardiac Resynchronization Therapy Devices Sales 2016-2021 (K Units)
Figure 29. APAC Implantable Cardiac Resynchronization Therapy Devices Revenue 2016-2021 ($ Millions)
Figure 30. Europe Implantable Cardiac Resynchronization Therapy Devices Sales 2016-2021 (K Units)
Figure 31. Europe Implantable Cardiac Resynchronization Therapy Devices Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Revenue 2016-2021 ($ Millions)
Figure 34. Americas Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Country in 2020
Figure 35. Americas Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Country in 2020
Figure 36. Americas Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type in 2020
Figure 37. Americas Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application in 2020
Figure 38. United States Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Region in 2020
Figure 43. APAC Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Regions in 2020
Figure 44. APAC Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type in 2020
Figure 45. APAC Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application in 2020
Figure 46. China Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Country in 2020
Figure 53. Europe Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Country in 2020
Figure 54. Europe Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type in 2020
Figure 55. Europe Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application in 2020
Figure 56. Germany Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Implantable Cardiac Resynchronization Therapy Devices Sales Market Share by Application in 2020
Figure 65. Egypt Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Implantable Cardiac Resynchronization Therapy Devices Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles

※본 조사보고서 [세계의 이식 가능형 심장 재동기 치료 장치 시장예측 2021년-2026년] (코드 : LPI-2201K00268) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 이식 가능형 심장 재동기 치료 장치 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 신경 조절 장치 및 이식형 주입 펌프 시장예측 2021년-2026년
LPI-2201K02398 / LP Information / 2021년 12월 / 본 조사보고서는 신경 조절 장치 및 이식형 주입 펌프의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도,...According to this latest study, the 2021 growth of Neuromodulation Devices and Implantable Infusion Pumps will have significant change from previous year. By the most conservative estimates of global Neuromodulation Devices and Implantable Infusion Pumps market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...

세계의 영상 유도 치료 장치 시장예측 2021년-2026년
LPI-2201K00264 / LP Information / 2021년 12월 / 본 조사보고서는 영상 유도 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Image Guided Therapy Devices will have significant change from previous year. By the most conservative estimates of global Image Guided Therapy Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 이식형 의료 기기용 폴리머 시장예측 2021년-2026년
LPI-2201K03235 / LP Information / 2021년 12월 / 본 조사보고서는 이식형 의료 기기용 폴리머의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Polymers for Implantable Medical Devices will have significant change from previous year. By the most conservative estimates of global Polymers for Implantable Medical Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 이식 가능형 펄스 발생기 시장예측 2021년-2026년
LPI-2201K00273 / LP Information / 2021년 12월 / 본 조사보고서는 이식 가능형 펄스 발생기의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Implantable Pulse Generator will have significant change from previous year. By the most conservative estimates of global Implantable Pulse Generator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 심박 조율기 시장예측 2021년-2026년
LPI-2201K02447 / LP Information / 2021년 12월 / 본 조사보고서는 심박 조율기의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pacemakers will have significant change from previous year. By the most conservative estimates of global Pacemakers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next...

세계의 이식형 제세동기 시장예측 2021년-2026년
LPI-2201K00269 / LP Information / 2021년 12월 / 본 조사보고서는 이식형 제세동기의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Implantable Cardioverter Defibrillator will have significant change from previous year. By the most conservative estimates of global Implantable Cardioverter Defibrillator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...